Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Hims & Hers Health Inc (NYSE: HIMS) closed at $35.95 up 4.54% from its previous closing price of $34.39. In other words, the price has increased by $4.54 from its previous closing price. On the day, 23.44 million shares were traded.
Ratios:
For a deeper understanding of Hims & Hers Health Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 03 ’25 when Becklund Irene sold 2,913 shares for $45.14 per share. The transaction valued at 131,493 led to the insider holds 4,406 shares of the business.
Pendarvis Christiane bought 12,500 shares of HIMS for $500,000 on Mar 05 ’25. On Mar 03 ’25, another insider, Becklund Irene, who serves as the Officer of the company, bought 2,913 shares for $45.14 each.
Valuation Measures:
As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 67.22, and their Forward P/E ratio for the next fiscal year is 41.80. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.16. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41 while its Price-to-Book (P/B) ratio in mrq is 16.65.
Stock Price History:
Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be 43.48%.
Shares Statistics:
A total of 212.46M shares are outstanding, with a floating share count of 181.48M. Insiders hold about 18.32% of the company’s shares, while institutions hold 73.74% stake in the company.
